COVID: CDC vaccine advisers to revisit benefits and risks of Johnson & Johnson vaccine
COVID: CDC vaccine advisers to revisit benefits and risks of Johnson & Johnson vaccine
By Jamie Gumbrecht and Elizabeth Cohen, CNN
(CNN) — The US Centers for Disease Control and Prevention’s vaccine advisers will meet on Thursday to revisit the benefits and risks for the Johnson & Johnson Covid-19 vaccine.
The Advisory Committee on Immunization Practices is scheduled to vote on “updated recommendations for use,” according to an agenda for the meeting posted online Wednesday.
The…